N-[(E)-(4-hydroxyphenyl)methylideneamino]-2-(2-methylbenzimidazol-1-yl)acetamide
C17H16N4O2 — CID 135721404
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(E)-(4-hydroxyphenyl)methylideneamino]-2-(2-methylbenzimidazol-1-yl)acetamide
N-[(E)-(4-hydroxyphenyl)methylideneamino]-2-(2-methylbenzimidazol-1-yl)acetamide (PubChem CID 135721404) has the molecular formula C17H16N4O2 and a molecular weight of 308.34 g/mol. Its IUPAC name is N-[(E)-(4-hydroxyphenyl)methylideneamino]-2-(2-methylbenzimidazol-1-yl)acetamide.
Molecular Properties
| Compound Name | N-[(E)-(4-hydroxyphenyl)methylideneamino]-2-(2-methylbenzimidazol-1-yl)acetamide |
|---|---|
| PubChem CID | 135721404 |
| Molecular Formula | C17H16N4O2 |
| Molecular Weight | 308.34 g/mol |
| Exact Mass | 308.13 |
| IUPAC Name | N-[(E)-(4-hydroxyphenyl)methylideneamino]-2-(2-methylbenzimidazol-1-yl)acetamide |
| SMILES | Cc1nc2ccccc2n1CC(=O)N/N=C/c1ccc(O)cc1 |
| InChI | InChI=1S/C17H16N4O2/c1-12-19-15-4-2-3-5-16(15)21(12)11-17(23)20-18-10-13-6-8-14(22)9-7-13/h2-10,22H,11H2,1H3,(H,20,23)/b18-10+ |
| InChIKey | ZZBXSWSHQYGVOA-VCHYOVAHSA-N |
| XLogP | 2.20 |
| TPSA | 79.51 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 308.34 |
| LogP ≤ 5 | 2.20 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hzone_phenol_B(215)', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135721404 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.